Literature DB >> 11358974

Analysis of macrophage activation in African trypanosomiasis.

D M Paulnock1, S P Coller.   

Abstract

African trypanosomes cause a fatal disease of man and animals that is characterized by extensive functional, histological, and pathological changes in the lymphoid tissues of infected hosts, including an increase in the numbers and activation state of macrophages. Macrophage activation during infection is the result of exposure of these cells to parasite components and host-derived IFN-gamma, produced in response to parasite antigens. The balance of these different activation signals may determine the outcome of infection. In the experiments described here, we assessed the ability of the variant surface glycoprotein (VSG) of the organism Trypanosoma brucei rhodesiense (T.b. rhodesiense) to activate macrophages directly. Our results demonstrate that macrophages bind and are activated by the VSG molecule. The resulting profile of activation differs from that stimulated by IFN-gamma. These results suggest that the interaction of host macrophages with VSG released during parasite infection may be a key component of trypanosomiasis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11358974

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  19 in total

Review 1.  Human African trypanosomiasis of the CNS: current issues and challenges.

Authors:  Peter G E Kennedy
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

2.  T-cell responses to the trypanosome variant surface glycoprotein are not limited to hypervariable subregions.

Authors:  Taylor R Dagenais; Karen P Demick; James D Bangs; Katrina T Forest; Donna M Paulnock; John M Mansfield
Journal:  Infect Immun       Date:  2008-10-20       Impact factor: 3.441

3.  Type I IFNs play a role in early resistance, but subsequent susceptibility, to the African trypanosomes.

Authors:  Rebecca Lopez; Karen P Demick; John M Mansfield; Donna M Paulnock
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

4.  Diminazene aceturate (Berenil) downregulates Trypanosoma congolense-induced proinflammatory cytokine production by altering phosphorylation of MAPK and STAT proteins.

Authors:  Shiby M Kuriakose; Chukwunonso Onyilagha; Rani Singh; Ping Jia; Jude E Uzonna
Journal:  Immunol Res       Date:  2019-02       Impact factor: 2.829

5.  Signal transduction, gene transcription, and cytokine production triggered in macrophages by exposure to trypanosome DNA.

Authors:  Tajie H Harris; Nicole M Cooney; John M Mansfield; Donna M Paulnock
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

6.  Delineation of diverse macrophage activation programs in response to intracellular parasites and cytokines.

Authors:  Shuyi Zhang; Charles C Kim; Sajeev Batra; James H McKerrow; P'ng Loke
Journal:  PLoS Negl Trop Dis       Date:  2010-03-30

7.  Proinflammatory cytokine expression in the early phase of Trypanosoma brucei rhodesiense infection in vervet monkeys (Cercopithecus aethiops).

Authors:  Naomi Maina; Joseph Maina Ngotho; Tom Were; John Kibuthu Thuita; David Mumo Mwangangi; John Maina Kagira; Joseph Mathu Ndung'u; Jeremy Sternberg
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

8.  Cooperative role of macrophages and neutrophils in host Antiprotozoan resistance in mice acutely infected with Cryptosporidium parvum.

Authors:  Dan Takeuchi; Vickie C Jones; Makiko Kobayashi; Fujio Suzuki
Journal:  Infect Immun       Date:  2008-06-02       Impact factor: 3.441

9.  Processing and presentation of variant surface glycoprotein molecules to T cells in African trypanosomiasis.

Authors:  Taylor R Dagenais; Bailey E Freeman; Karen P Demick; Donna M Paulnock; John M Mansfield
Journal:  J Immunol       Date:  2009-08-12       Impact factor: 5.422

10.  Dermal bacterial LPS-stimulation reduces susceptibility to intradermal Trypanosoma brucei infection.

Authors:  Omar A Alfituri; Enock M Mararo; Pieter C Steketee; Liam J Morrison; Neil A Mabbott
Journal:  Sci Rep       Date:  2021-05-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.